posts author

–  License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters – Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strategy SEOUL, South Korea–Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company …

Continue reading

Without a doubt, obesity is a global problem that leads to several other major health conditions. According to the National Health and Nutrition Examination Surveys, nearly 69% of adults are obese. However, fat accumulation is crucial for the survival of hibernating mammals in winter. Hibernation is a unique quirk of …

Continue reading

ROCKVILLE, MD–On January 2nd, the Psomagen–Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US and …

Continue reading

As per a recent study by Dr. Kaitlin Wade from the University of Bristol. It has been discovered that a particular type of bacteria in the gut microbiome can increase the risk of bowel cancer by 2% to 15%. This bacteria is known as Bacteroidales in medical terms. And is …

Continue reading

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading